Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics To Award Free Sequencing Under Cancer Grant Program

Premium

This story was originally published June 30.

Complete Genomics this week launched a cancer grant program in which it will award four "innovative cancer research projects" with whole-genome sequencing of four matched tumor/normal pairs.

The company will select two entries from the US and two from Europe.

Applications are due by July 29 and winners will be notified after Aug. 12. Further information about the program is available here.

While only four winners will be chosen by the company's internal panel of scientific experts, all applicants will be eligible for a discount on a whole-human genome sequencing project, although the company did not disclose how much of a discount.

Complete Genomics CEO Cliff Reid said in a statement that the projects would help "gain insights into the characterization and possible treatment" of cancer.

Reid has often cited cancer sequencing as a key opportunity for the company and earlier this year disclosed that the firm is developing a "cancer product" to identify differences between tumor and normal cells that it intends to launch some time this year (CSN 3/16/2011).

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.